Literature DB >> 15968956

Development of the human umbilical vein scaffold for cardiovascular tissue engineering applications.

Joel Daniel1, Koki Abe, Peter S McFetridge.   

Abstract

Biologic function and the mechanical performance of vascular grafting materials are important predictors of graft patency. As such, "functional" materials that improve biologic integration and function have become increasingly sought after. An important alternative to synthetic materials is the use of biomaterials derived from ex vivo tissues that retain significant biologic and mechanical function. Unfortunately, inconsistent mechanical properties that result from tedious, time consuming, manual dissection methods have reduced the potential usefulness of many of these materials. We describe the preparation of the human umbilical vein (HUV) for use as an acellular, three-dimensional, vascular scaffold using a novel, automated dissection methodology. The goal of this investigation was to determine the effectiveness of the autodissection methodology to yield an ex vivo biomaterial with improved uniformity and reduced variance. Mechanical properties, including burst pressure, compliance, uniaxial tension testing, and suture holding capacity, were assessed to determine the suitability of the HUV scaffold for vascular tissue engineering applications. The automated methodology results in a tubular scaffold with significantly reduced sample to sample variation, requiring significantly less time to excise the vein from the umbilical cord than manual dissection methods. Short-term analysis of the interactions between primary human vascular smooth muscle cells and fibroblasts HUV scaffold have shown an excellent potential for cellular integration by native cellular remodeling processes. Our work has shown that the HUV scaffold is mechanically sound, uniform, and maintains its biphasic stress-strain relationship throughout tissue processing. By maintaining the mechanical properties of the native blood vessels, in concert with promising cellular interactions, the HUV scaffold may lead to improved grafts for vascular reconstructive surgeries.

Entities:  

Mesh:

Year:  2005        PMID: 15968956     DOI: 10.1097/01.mat.0000160872.41871.7e

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  21 in total

1.  Novel human-derived extracellular matrix induces in vitro and in vivo vascularization and inhibits fibrosis.

Authors:  Marc C Moore; Vittoria Pandolfi; Peter S McFetridge
Journal:  Biomaterials       Date:  2015-02-11       Impact factor: 12.479

2.  Removal of an abluminal lining improves decellularization of human umbilical arteries.

Authors:  Ho-Yi Tuan-Mu; Yi-Hao Chang; Jin-Jia Hu
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

3.  Development of a mechanically tuneable 3D scaffold for vascular reconstruction.

Authors:  Maritza Rodriguez; Cassandra Juran; Mark McClendon; Cyril Eyadiel; Peter S McFetridge
Journal:  J Biomed Mater Res A       Date:  2012-07-24       Impact factor: 4.396

4.  Preimplantation processing of ex vivo-derived vascular biomaterials: effects on peripheral cell adhesion.

Authors:  Joseph S Uzarski; Aurore B Van De Walle; Peter S McFetridge
Journal:  J Biomed Mater Res A       Date:  2012-07-24       Impact factor: 4.396

5.  Directed oxygen gradients initiate a robust early remodeling response in engineered vascular grafts.

Authors:  Marc Moore; Ruben Moore; Peter S McFetridge
Journal:  Tissue Eng Part A       Date:  2013-05-06       Impact factor: 3.845

6.  In vitro method for real-time, direct observation of cell-vascular graft interactions under simulated blood flow.

Authors:  Joseph S Uzarski; Aurore B Van de Walle; Peter S McFetridge
Journal:  Tissue Eng Part C Methods       Date:  2013-08-24       Impact factor: 3.056

7.  Physiologically Modeled Pulse Dynamics to Improve Function in In Vitro-Endothelialized Small-Diameter Vascular Grafts.

Authors:  Joseph S Uzarski; Jhon Cores; Peter S McFetridge
Journal:  Tissue Eng Part C Methods       Date:  2015-06-24       Impact factor: 3.056

8.  Mass transfer trends occurring in engineered ex vivo tissue scaffolds.

Authors:  Marc Moore; Malisa Sarntinoranont; Peter McFetridge
Journal:  J Biomed Mater Res A       Date:  2012-05-24       Impact factor: 4.396

9.  Improved recellularization of ex vivo vascular scaffolds using directed transport gradients to modulate ECM remodeling.

Authors:  Zehra Tosun; Peter S McFetridge
Journal:  Biotechnol Bioeng       Date:  2013-04-29       Impact factor: 4.530

10.  The consequence of biologic graft processing on blood interface biocompatibility and mechanics.

Authors:  Aurore B Van de Walle; Joseph S Uzarski; Peter S McFetridge
Journal:  Cardiovasc Eng Technol       Date:  2015-09       Impact factor: 2.495

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.